SCHEMBL16558598

SCHEMBL16558598

CC1=CC[C@@H](CC=O)C1(C)C

nearest known ligand 0.39

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15316770 1.00 USP2 (0.39) USP2NPSR1TDP1
SCHEMBL1782826 1.00 USP2 (0.39) USP2NPSR1TDP1
SCHEMBL2431308 0.83 USP2 (0.35) USP2NPSR1
SCHEMBL2427834 0.83 USP2 (0.35) USP2NPSR1
SCHEMBL2424981 0.83 USP2 (0.35) USP2NPSR1
SCHEMBL2427596 0.83 USP2 (0.35) USP2NPSR1
SCHEMBL2424984 0.83 USP2 (0.35) USP2NPSR1
SCHEMBL2428480 0.83 USP2 (0.35) USP2NPSR1
SCHEMBL2427837 0.83 USP2 (0.35) USP2NPSR1
SCHEMBL2428359 0.83 USP2 (0.35) USP2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4136067-B1 ODORANTS AND COMPOSITIONS COMPRISING ODORANTS S H KELKAR AND COMPANY LTD (IN) 2026-04-15 EP disclosed
US-20260069516-A1 FRAGRANCE COMPOSITION TAKASAGO INTERNATIONAL CORPORATION (JP) 2026-03-12 US disclosed
US-12545852-B2 Odorants and compositions comprising odorants S H KELKAR AND COMPANY LIMITED (IN) 2026-02-10 US disclosed
EP-3697878-B1 USE OF ODORANTS AND COMPOSITIONS COMPRISING ODORANTS S H KELKAR AND COMPANY LTD (IN) 2026-01-28 EP disclosed
US-12522780-B2 Odorants and compositions comprising odorants S H KELKAR AND COMPANY LIMITED (IN) 2026-01-13 US disclosed
US-12516012-B2 Odorous compounds and method of preparation thereof S.H. Kelkar and Company Limited (IN) 2026-01-06 US disclosed
US-12480070-B2 Odorants and compositions comprising odorants S H KELKAR AND COMPANY LIMITED (IN) 2025-11-25 US disclosed
US-20250333555-A1 COMPOSITION AND METHOD FOR PRODUCING ARTICLE CANON KK (JP) 2025-10-30 US disclosed
EP-4628567-A1 FRAGRANCE COMPOSITION Takasago International Corporation (JP) 2025-10-08 EP disclosed
WO-2025094102-A1 ODOROUS COMPOUNDS AND METHOD OF PREPARATION THEREOF S H KELKAR AND COMPANY LIMITED (IN) 2025-05-08 WO disclosed
CN-105517985-B Spice composition 高砂香料工业株式会社 2018-09-11 CN disclosed
US-9643908-B2 Fragrance composition TAKASAGO INTERNATIONAL CORPORATION (JP) 2017-05-09 US disclosed
US-9643908-B2 Fragrance composition TAKASAGO INTERNATIONAL CORPORATION (JP) 2017-05-09 US disclosed
US-9643908-B2 Fragrance composition TAKASAGO INTERNATIONAL CORPORATION (JP) 2017-05-09 US disclosed
US-20160207862-A1 FRAGRANCE COMPOSITION TAKASAGO INTERNATIONAL CORPORATION (JP) 2016-07-21 US disclosed
US-20160207862-A1 FRAGRANCE COMPOSITION TAKASAGO INTERNATIONAL CORPORATION (JP) 2016-07-21 US disclosed
US-20160207862-A1 FRAGRANCE COMPOSITION TAKASAGO INTERNATIONAL CORPORATION (JP) 2016-07-21 US disclosed
EP-3042891-A1 FRAGRANCE COMPOSITION Takasago International Corporation (JP) 2016-07-13 EP disclosed
EP-3042891-A1 FRAGRANCE COMPOSITION Takasago International Corporation (JP) 2016-07-13 EP disclosed
WO-2015034084-A1 FRAGRANCE COMPOSITION 高砂香料工業株式会社 (JP) 2015-03-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160207862-A1 FRAGRANCE COMPOSITION CYP51A1, TRPA1, CYP1A1 USP2 3195/4885NPSR1 1254/4885TDP1 3102/4885
US-12545852-B2 Odorants and compositions comprising odorants ENY2, CDY1; CDY1B, CHRM5 USP2 2781/4885NPSR1 3426/4885TDP1 1681/4885
US-20260069516-A1 FRAGRANCE COMPOSITION FDFT1, ECH1, CYP1B1 USP2 4496/4885NPSR1 1074/4885TDP1 2971/4885
US-12480070-B2 Odorants and compositions comprising odorants CDY1; CDY1B, ENY2, DPY30 USP2 2400/4885NPSR1 417/4885TDP1 3376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.